Molecule that 'lights up' cancer accelerating toward FDA approval
The U.S. Food and Drug Administration has granted fast-track status to a Purdue University scientist's optical imaging technology that may one day significantly improve outcomes for pancreatic cancer patients.
Oct 27, 2016